Both stocks have made significant breakthroughs. Among the qualities a biotech company needs to be successful, being innovative is one of the most important. It's easy to understand why. Although ...

after analysts at JPMorgan Chase & Co. predicted the Danish biotech firm’s experimental weight-loss drug petrelintide could ...

M uch to the chagrin of investors looking to get rich quickly with a biopharma investment, the drug development cycle is, by ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

STAT's Readout LOUD podcast discusses how Trump's second term and the MAHA movement could affect FDA regulation, the ...

The firm had received notice last year that it was out of compliance with a requirement to maintain a minimum $15 million market value of publicly held shares.

Moderna Inc.'s stock was higher but off its early highs Thursday, after the company's third-quarter earnings showed an unexpected profit as well as revenue that beat estimates by a wide margin. The ...

Opthea is a clinical-stage biotech firm developing Sozinibercept, targeting VEGF-C and VEGF-D for wet AMD, with Phase 3 ...

Shares of TransMedics (NASDAQ: TMDX), a biotech company that specializes in organ transportation, were tumbling last month ...

In August, Trevena underwent a reverse stock split, a move often enacted when a company’s share price dips too low. The split wasn’t enough to stave off delisting, with Nasdaq removing Trevena’s stock ...

Moderna shares jumped after the biotechnology company reported higher-than-expected sales of its Covid-19 vaccine and backed ...

Moderna Inc.’s stock jumped 9% early Thursday, after the company’s third-quarter earnings showed an unexpected profit and revenue that beat estimates by a wide margin. The news cheered investors comin ...